Advancing Sustainable QC with Monocyte Activation Testing

QC laboratories today face increasing pressure to meet sustainability goals while delivering performance, efficiency, and throughput. Lonza’s sustainable QC ecosystem brings together sustainable reagents, validated automation, and industry-standard data solutions to help reduce QC risk, strengthen supply security, and enable confident decision-making.

The Monocyte Activation Test (MAT) has gained increasing adoption as companies move toward more sustainable testing options. Modern methods such as MAT and recombinant Factor C assays are now recognized as reliable, resource-efficient approaches for detecting both endotoxins and non-endotoxin pyrogens. As animal-based pyrogen tests are phased out, MAT is becoming the leading in-vitro standard.

Lonza’s PyroCell® MAT Systems provide a sustainable alternative for detecting endotoxins and non-endotoxin pyrogens. Lonza offers flexible, validated system options designed to meet product-specific and sustainability requirements. These systems utilize human immune cells to deliver accurate and reliable results, supporting testing of complex biologics, including vaccines and gene therapies.

Even with advanced in-vitro methods, endotoxin masking remains a key challenge that can lead to false-negative results and compliance risks. In a collaborative study conducted by Lonza and Solvias, the teams demonstrated how PyroCell® MAT combined with the PYROSPERSE® Dispersing Agent can enhance pyrogen detection in challenging matrices. For teams looking to better understand endotoxin masking and its impact on MAT performance, the on-demand webinar “Disrupting endotoxin masking in the Monocyte Activation Test” provides practical insights grounded in this study and real-world testing experience.

Lonza is your partner in advancing sustainable, reliable, and efficient QC testing. We help you reduce QC risk, strengthen supply security, and confidently meet your sustainability goals.

Switch to Lonza